We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
South Africa's Department of Health has announced its new multimillion-dollar plan to combat HIV, which includes significant funding for HIV treatment, through 2011.
The U.S. Centers for Disease Control and Prevention (CDC) has released new safety data on Merck's RotaTeq rotavirus vaccine showing that the vaccine does not pose an elevated risk for intussusception, the most common cause of bowel obstruction in infants.
To help companies move to electronic common technical document (eCTD) format, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) announced it will accept electronic submissions that are compliant with the folder structure and naming conventions of the eCTD standard but that do not have an extensible markup language (XML) backbone.
Xechem International announced that its subsidiary Xechem Pharmaceuticals Nigeria expects to soon be able to scale up production of its drug for sickle cell disease with the arrival of new equipment.
The FDA has requested that all manufacturers of sedative-hypnotic drug products strengthen their product labeling to include stronger language about potential risks.
The Chinese Ministry of Health has announced a new rule mandating that doctors use the generic names of drugs when writing prescriptions, the country's government news agency Xinhua has reported.
A Nigerian high court has ruled in favor of Pfizer in a patent infringement suit brought against two local companies, Tyonex Nigeria and Ebamic Pharmacy, for selling an unauthorized drug containing the same active ingredient as Pfizer's hypertension drug Norvasc, reports the Lagos, Nigeria-based daily newspaper Vanguard.
GlaxoSmithKline's (GSK) kinase inhibitor Tykerb has gained FDA approval for use in combination with Roche's oral chemotherapeutic Xeloda for the treatment of advanced metastatic breast cancer specifically in tumors that produce an excess of the HER2 protein.